MYRIAD GENETICS, INC. Research and Development Expense
MYRIAD GENETICS, INC. (MYGN) reported Research and Development Expense of $25.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-31
- MYRIAD GENETICS, INC. research and development expense for the quarter ending 2026-06-30 was $25.00M, a 2.34% decline year-over-year.
- MYRIAD GENETICS, INC. research and development expense for the quarter ending 2026-03-31 was $27.10M, a 1.45% decline year-over-year.
- MYRIAD GENETICS, INC. research and development expense for the quarter ending 2025-12-31 was $25.50M, a 20.81% decline year-over-year.
- MYRIAD GENETICS, INC. research and development expense for the quarter ending 2025-09-30 was $28.20M, a 1.05% decline year-over-year.
- MYRIAD GENETICS, INC. research and development expense for fiscal 2025 was $106.80M, a 5.82% decline from fiscal 2024.
- MYRIAD GENETICS, INC. research and development expense for fiscal 2024 was $113.40M, a 27.85% increase from fiscal 2023.
- MYRIAD GENETICS, INC. research and development expense for fiscal 2023 was $88.70M, a 3.86% increase from fiscal 2022.
- MYRIAD GENETICS, INC. research and development expense for fiscal 2022 was $85.40M, a 4.27% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.00M 10-Q · filed 2026-07-31 | $52.10M 10-Q · filed 2026-07-31 | $77.60M derived: sum of 3 quarters · filed 2026-07-31 | $105.80M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $27.10M 10-Q · filed 2026-05-06 | $52.60M derived: sum of 2 quarters · filed 2026-05-06 | $80.80M derived: sum of 3 quarters · filed 2026-05-06 | $106.40M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $53.70M derived: sum of 2 quarters · filed 2026-02-24 | $79.30M derived: sum of 3 quarters · filed 2026-07-31 | $106.80M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $28.20M 10-Q · filed 2025-11-04 | $53.80M derived: sum of 2 quarters · filed 2026-07-31 | $81.30M 10-Q · filed 2025-11-04 | $113.50M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $25.60M 10-Q · filed 2026-07-31 | $53.10M 10-Q · filed 2026-07-31 | $85.30M derived: sum of 3 quarters · filed 2026-07-31 | $113.80M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $27.50M 10-Q · filed 2026-05-06 | $59.70M derived: sum of 2 quarters · filed 2026-05-06 | $88.20M derived: sum of 3 quarters · filed 2026-05-06 | $115.30M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $32.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $60.70M derived: sum of 2 quarters · filed 2026-02-24 | $87.80M derived: sum of 3 quarters · filed 2026-02-24 | $113.40M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $28.50M 10-Q · filed 2025-11-04 | $55.60M derived: sum of 2 quarters · filed 2025-11-04 | $81.20M 10-Q · filed 2025-11-04 | $101.50M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $27.10M 10-Q · filed 2025-08-06 | $52.70M 10-Q · filed 2025-08-06 | $73.00M derived: sum of 3 quarters · filed 2026-02-24 | $97.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $24.90M 10-Q · filed 2025-05-07 | $45.90M derived: sum of 2 quarters · filed 2026-02-24 | $69.90M derived: sum of 3 quarters · filed 2026-02-24 | $91.10M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $45.00M derived: sum of 2 quarters · filed 2026-02-24 | $66.20M derived: sum of 3 quarters · filed 2026-02-24 | $88.70M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $24.00M 10-Q · filed 2024-11-08 | $45.20M derived: sum of 2 quarters · filed 2024-11-08 | $67.70M 10-Q · filed 2024-11-08 | $91.10M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $21.20M 10-Q · filed 2024-08-07 | $43.70M 10-Q · filed 2024-08-07 | $67.10M derived: sum of 3 quarters · filed 2025-02-28 | $87.60M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $22.50M 10-Q · filed 2024-05-08 | $45.90M derived: sum of 2 quarters · filed 2025-02-28 | $66.40M derived: sum of 3 quarters · filed 2025-02-28 | $86.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $23.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $43.90M derived: sum of 2 quarters · filed 2025-02-28 | $64.20M derived: sum of 3 quarters · filed 2025-02-28 | $85.40M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $20.50M 10-Q · filed 2023-11-07 | $40.80M derived: sum of 2 quarters · filed 2023-11-07 | $62.00M 10-Q · filed 2023-11-07 | $82.50M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $20.30M 10-Q · filed 2023-08-04 | $41.50M 10-Q · filed 2023-08-04 | $62.00M derived: sum of 3 quarters · filed 2024-02-28 | $80.80M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $21.20M 10-Q · filed 2023-05-04 | $41.70M derived: sum of 2 quarters · filed 2024-02-28 | $60.50M derived: sum of 3 quarters · filed 2024-02-28 | $80.00M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $39.30M derived: sum of 2 quarters · filed 2024-02-28 | $58.80M derived: sum of 3 quarters · filed 2024-02-28 | $81.90M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $18.80M 10-Q · filed 2022-11-02 | $38.30M derived: sum of 2 quarters · filed 2022-11-02 | $61.40M 10-Q · filed 2022-11-02 | $79.60M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $19.50M 10-Q · filed 2022-08-05 | $42.60M 10-Q · filed 2022-08-05 | $60.80M derived: sum of 3 quarters · filed 2022-08-05 | $78.40M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $23.10M 10-Q · filed 2022-05-06 | $41.30M derived: sum of 2 quarters · filed 2022-05-06 | $58.90M derived: sum of 3 quarters · filed 2022-05-06 | $76.30M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $18.20M 10-KT · filed 2021-03-16 | $35.80M 10-K · filed 2023-03-01 | $53.20M derived: sum of 3 quarters · filed 2021-11-04 | $73.30M 10-K · filed 2022-02-25 | ||||
| 2020-09-30 | $17.60M 10-Q · filed 2021-11-04 | $35.00M derived: sum of 2 quarters · filed 2021-11-04 | $54.70M 10-Q · filed 2021-11-04 | $73.50M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $17.40M 10-Q · filed 2021-08-04 | $37.10M 10-Q · filed 2021-08-04 | $55.90M derived: sum of 3 quarters · filed 2021-08-04 | $77.20M 10-K · filed 2023-03-01 | ||||
| 2020-03-31 | $19.70M 10-Q · filed 2021-05-05 | $38.50M derived: sum of 2 quarters · filed 2021-05-05 | $59.80M 10-Q · filed 2020-05-06 | $80.70M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $18.80M 10-KT · filed 2021-03-16 | $40.10M 10-K · filed 2022-02-25 | $61.00M derived: sum of 3 quarters · filed 2021-03-16 | $82.50M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-09-30 | $21.30M 10-KT · filed 2021-03-16 | $42.20M derived: sum of 2 quarters · filed 2021-03-16 | $63.70M derived: sum of 3 quarters · filed 2021-03-16 | $86.10M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-06-30 | $20.90M 10-KT · filed 2021-03-16 | $42.40M derived: sum of 2 quarters · filed 2021-03-16 | $64.80M derived: sum of 3 quarters · filed 2021-03-16 | $85.90M 10-K · filed 2022-02-25 | ||||
| 2019-03-31 | $21.50M 10-KT · filed 2021-03-16 | $43.90M derived: sum of 2 quarters · filed 2021-03-16 | $65.00M 10-Q · filed 2020-05-06 | $82.70M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | $22.40M 10-KT · filed 2021-03-16 | $43.50M 10-Q · filed 2020-02-07 | $61.20M derived: sum of 3 quarters · filed 2021-03-16 | $79.70M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-09-30 | $21.10M 10-KT · filed 2021-03-16 | $38.80M derived: sum of 2 quarters · filed 2021-03-16 | $57.30M derived: sum of 3 quarters · filed 2021-03-16 | $74.10M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-06-30 | $17.70M 10-K · filed 2019-08-13 | $36.20M derived: sum of 2 quarters · filed 2019-08-13 | $53.00M derived: sum of 3 quarters · filed 2019-08-13 | $70.80M 10-KT · filed 2021-03-16 | ||||
| 2018-03-31 | $18.50M 10-K · filed 2019-08-13 | $35.30M derived: sum of 2 quarters · filed 2019-08-13 | $53.10M 10-Q · filed 2019-05-08 | $71.90M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-12-31 | $16.80M 10-K · filed 2019-08-13 | $34.60M 10-Q · filed 2019-02-06 | $53.40M derived: sum of 3 quarters · filed 2019-08-13 | $71.00M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-09-30 | $17.80M 10-K · filed 2019-08-13 | $36.60M derived: sum of 2 quarters · filed 2019-08-13 | $54.20M derived: sum of 3 quarters · filed 2019-08-13 | $72.80M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-06-30 | $18.80M 10-K · filed 2018-08-24 | $36.40M derived: sum of 2 quarters · filed 2018-08-24 | $55.00M derived: sum of 3 quarters · filed 2018-08-24 | $74.40M 10-K · filed 2019-08-13 | ||||
| 2017-03-31 | $17.60M 10-K · filed 2018-08-24 | $36.20M derived: sum of 2 quarters · filed 2018-08-24 | $55.60M 10-Q · filed 2018-05-09 | $75.10M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-12-31 | $18.60M 10-K · filed 2018-08-24 | $38.00M 10-Q · filed 2018-02-07 | $57.50M derived: sum of 3 quarters · filed 2018-08-24 | $74.70M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-09-30 | $19.40M 10-K · filed 2018-08-24 | $38.90M derived: sum of 2 quarters · filed 2018-08-24 | $56.10M derived: sum of 3 quarters · filed 2018-08-24 | $72.80M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-06-30 | $19.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $36.70M derived: sum of 2 quarters · filed 2018-08-24 | $53.40M derived: sum of 3 quarters · filed 2018-08-24 | $70.60M 10-K · filed 2018-08-24 | ||||
| 2016-03-31 | $17.20M 10-Q · filed 2017-05-03 | $33.90M derived: sum of 2 quarters · filed 2017-05-03 | $51.10M 10-Q · filed 2017-05-03 | $69.80M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-12-31 | $16.70M 10-Q · filed 2017-02-08 | $33.90M 10-Q · filed 2017-02-08 | $52.60M derived: sum of 3 quarters · filed 2018-08-24 | $69.30M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-09-30 | $17.20M 10-Q · filed 2016-11-02 | $35.90M derived: sum of 2 quarters · filed 2018-08-24 | $52.60M derived: sum of 3 quarters · filed 2018-08-24 | $70.10M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2015-06-30 | $18.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $35.40M derived: sum of 2 quarters · filed 2018-08-24 | $52.90M derived: sum of 3 quarters · filed 2018-08-24 | $75.50M 10-K · filed 2018-08-24 | ||||
| 2015-03-31 | $16.70M 10-Q · filed 2016-05-04 | $16.67M 10-Q · filed 2015-05-06 | $34.20M derived: sum of 2 quarters · filed 2016-05-04 | $56.80M 10-Q · filed 2016-05-04 | $56.79M 10-Q · filed 2015-05-06 | $77.01M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-12-31 | $17.50M 10-Q · filed 2016-02-03 | $17.50M 10-Q · filed 2015-02-04 | $40.10M 10-Q · filed 2016-02-03 | $40.12M 10-Q · filed 2015-02-04 | $60.31M derived: sum of 3 quarters · filed 2016-08-10 | $73.71M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-09-30 | $22.60M 10-Q · filed 2015-11-04 | $22.61M 10-Q · filed 2014-11-05 | $42.81M derived: sum of 2 quarters · filed 2016-08-10 | $56.21M derived: sum of 3 quarters · filed 2016-08-10 | $73.30M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | $20.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $33.61M derived: sum of 2 quarters · filed 2016-08-10 | $50.70M derived: sum of 3 quarters · filed 2016-08-10 | $67.50M 10-K · filed 2016-08-10 | $67.48M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $13.40M 10-Q · filed 2015-05-06 | $30.49M derived: sum of 2 quarters · filed 2015-05-06 | $47.29M 10-Q · filed 2015-05-06 | $61.87M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $17.09M 10-Q · filed 2015-02-04 | $33.89M 10-Q · filed 2015-02-04 | $48.47M derived: sum of 3 quarters · filed 2015-08-12 | $62.09M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $16.80M 10-Q · filed 2014-11-05 | $31.38M derived: sum of 2 quarters · filed 2015-08-12 | $45.00M derived: sum of 3 quarters · filed 2015-08-12 | $59.10M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | $14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $28.19M derived: sum of 2 quarters · filed 2015-08-12 | $42.30M derived: sum of 3 quarters · filed 2015-08-12 | $53.70M 10-K · filed 2015-08-12 | $53.71M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $13.62M 10-Q · filed 2014-05-07 | $27.73M derived: sum of 2 quarters · filed 2014-05-07 | $39.13M 10-Q · filed 2014-05-07 | $51.27M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | $14.11M 10-Q · filed 2014-02-05 | $25.51M 10-Q · filed 2014-02-05 | $37.65M derived: sum of 3 quarters · filed 2014-08-13 | $49.40M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $11.40M 10-Q · filed 2013-11-12 | $23.54M derived: sum of 2 quarters · filed 2014-08-13 | $35.30M derived: sum of 3 quarters · filed 2014-08-13 | $45.54M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $23.90M derived: sum of 2 quarters · filed 2014-08-13 | $34.14M derived: sum of 3 quarters · filed 2014-08-13 | $42.65M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | $11.75M 10-Q · filed 2013-05-08 | $22.00M derived: sum of 2 quarters · filed 2013-05-08 | $30.50M 10-Q · filed 2013-05-08 | $39.73M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | $10.24M 10-Q · filed 2013-02-06 | $18.75M 10-Q · filed 2013-02-06 | $27.98M derived: sum of 3 quarters · filed 2013-08-14 | $34.65M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | $8.51M 10-Q · filed 2012-11-09 | $17.74M derived: sum of 2 quarters · filed 2013-08-14 | $24.40M derived: sum of 3 quarters · filed 2013-08-14 | $30.50M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | $9.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $15.90M derived: sum of 2 quarters · filed 2013-08-14 | $21.99M derived: sum of 3 quarters · filed 2013-08-14 | $27.75M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | $6.67M 10-Q · filed 2012-05-02 | $12.76M derived: sum of 2 quarters · filed 2012-05-02 | $18.52M 10-Q · filed 2012-05-02 | $23.77M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | $6.09M 10-Q · filed 2012-02-01 | $11.85M 10-Q · filed 2012-02-01 | $17.11M derived: sum of 3 quarters · filed 2012-08-15 | $22.99M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-09-30 | $5.76M 10-Q · filed 2011-11-02 | $11.02M derived: sum of 2 quarters · filed 2012-08-15 | $16.90M derived: sum of 3 quarters · filed 2012-08-15 | $21.96M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-06-30 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $11.14M derived: sum of 2 quarters · filed 2012-08-15 | $16.20M derived: sum of 3 quarters · filed 2012-08-15 | $21.87M 10-K · filed 2012-08-15 | ||||
| 2010-03-31 | $5.88M 10-Q · filed 2011-05-04 | $10.94M derived: sum of 2 quarters · filed 2011-05-04 | $16.62M 10-Q · filed 2011-05-04 | |||||
| 2009-12-31 | $5.06M 10-Q · filed 2011-02-01 | $10.73M 10-Q · filed 2011-02-01 | ||||||
| 2009-09-30 | $5.68M 10-Q · filed 2010-11-03 | |||||||
| 2009-06-30 | $17.91M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |